2016 Press Releases

Keyword Search
2016 | 2015 | 2014 | 2013 | 2012
05/23/16Navidea Provides Financing UpdateDownload PDF
05/17/16Navidea Reports First Quarter 2016 Financial ResultsDownload PDF
05/10/16Navidea Biopharmaceuticals to Announce First Quarter 2016 Financial Results on May 17, 2016Download PDF
05/03/16Navidea and Macrophage Therapeutics to Provide Development Program UpdateDownload PDF
04/26/16Navidea Appoints Jed Latkin as Interim Chief Operating OfficerDownload PDF
04/15/16Navidea and Macrophage Therapeutics to Provide Business UpdateDownload PDF
04/04/16Navidea Updates Clinical Development Plan for Diagnostic Use of Lymphoseek® IV in Rheumatoid ArthritisDownload PDF
03/23/16Navidea Announces Fourth Quarter and Full Year 2015 ResultsDownload PDF
03/21/16Navidea Biopharmaceuticals to Announce Fourth Quarter and Full Year 2015 Results on March 23, 2016Download PDF
03/14/16Navidea Biopharmaceuticals Announces Delay in Filing of Form 10-KDownload PDF
03/14/16Navidea and Platinum Enter Into Agreement Reaffirming Loan Obligations and Agreeing to Standstill ProvisionsDownload PDF
03/10/16Immunotherapeutic Potential of Manocept™ Platform Reviewed in the Journal Nuclear Medicine and BiologyDownload PDF
02/11/16Navidea Biopharmaceuticals Enrolls First Patient in Cervical Cancer Study of Lymphoseek®Download PDF
02/04/16Navidea Biopharmaceuticals to Present at 2016 BIO CEO & Investor ConferenceDownload PDF
02/02/16Navidea Provides Update on Lymphoseek® and Immunodiagnostics Development PipelineDownload PDF
01/11/16Navidea Meets Guidance With 2015 Unaudited Lymphoseek® Sales of $10.2 MillionDownload PDF
01/11/16Navidea Appoints Anton Gueth Chairman of the BoardDownload PDF
01/06/16Navidea Biopharmaceuticals Enrolls First Patient in Pediatric Trial of Lymphoseek®Download PDF
01/04/16Navidea Biopharmaceuticals to Present at Biotech Showcase 2016Download PDF